In America’s health care system, patients benefit from the balance between availability of innovative, life-saving medicines and access to lower-cost generic medicines; in fact, generic medicines account for 74 percent of prescriptions written in the U.S. This balance is based on a variety of factors. Unfortunately, one of those factors is currently under attack in … Continue reading “Protect Patent Settlements for Washington’s Biotech Future”
Author: Diane Bieri
Diane Bieri serves as Executive Vice President and General Counsel for the Pharmaceutical Research and Manufacturers of America (PhRMA), an association representing the leading research-based pharmaceutical and biotechnology companies in the United States. Ms. Bieri joined PhRMA in June 2004 as Assistant General Counsel and Compliance Officer. Prior to joining PhRMA, Ms. Bieri was a partner with the law firm Howrey LLP, specializing in antitrust and complex commercial litigation. While in private practice, Ms. Bieri represented clients in the pharmaceutical, medical device, and contractor services industries, among others. Ms. Bieri is a 1995 graduate (cum laude) of the Georgetown University Law Center and a 1992 graduate (summa cum laude) of the University of Pittsburgh.